<table class="naaccr-summary-table naaccr-borders">
    <tr>
        <th class="naaccr-summary-header naaccr-borders">Alternate Name</th>
        <th class="naaccr-summary-header naaccr-borders">Item#</th>
        <th class="naaccr-summary-header naaccr-borders">Length</th>
        <th class="naaccr-summary-header naaccr-borders">Source of Standard</th>
        <th class="naaccr-summary-header naaccr-borders">Column #</th>
    </tr>
    <tr>
        <td class="naaccr-summary-cell naaccr-borders">Regional Treatment Modality (CoC)</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">1570</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">2</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">CoC</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">1607-1608</td>
    </tr>
</table>

<br/><b>Description</b><br/>
Records the dominant modality of radiation therapy used to deliver the clinically most significant regional dose to the primary volume of interest during the first course of treatment.

<br/><br/><b>Rationale</b><br/>
Radiation treatment frequently is delivered in two or more phases that can be summarized as regional and boost treatments. To evaluate patterns of radiation oncology care, it is necessary to know which radiation resources were employed in the delivery of therapy. For outcomes analysis, the modalities used for each of these phases can be very important.

<br/><br/><b>
  Codes
</b><br/>
<table class="naaccr-codes-table">
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">00</td>
        <td class="naaccr-codes-cell">No radiation treatment</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">20</td>
        <td class="naaccr-codes-cell">External beam, NOS</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">21</td>
        <td class="naaccr-codes-cell">Orthovoltage</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">22</td>
        <td class="naaccr-codes-cell">Cobalt-60, Cesium-137</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">23</td>
        <td class="naaccr-codes-cell">Photons (2-5 MV)</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">24</td>
        <td class="naaccr-codes-cell">Photons (6-10 MV)</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">25</td>
        <td class="naaccr-codes-cell">Photons (11-19 MV)</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">26</td>
        <td class="naaccr-codes-cell">Photons (> 19 MV)</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">27</td>
        <td class="naaccr-codes-cell">Photons (mixed energies)</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">28</td>
        <td class="naaccr-codes-cell">Electrons</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">29</td>
        <td class="naaccr-codes-cell">Photons and electrons mixed</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">30</td>
        <td class="naaccr-codes-cell">Neutrons, with or without photons/electrons</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">31</td>
        <td class="naaccr-codes-cell">IMRT</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">32</td>
        <td class="naaccr-codes-cell">Conformal or 3-D therapy</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">40</td>
        <td class="naaccr-codes-cell">Protons</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">41</td>
        <td class="naaccr-codes-cell">Stereotactic radiosurgery, NOS</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">42</td>
        <td class="naaccr-codes-cell">Linac radiosurgery</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">43</td>
        <td class="naaccr-codes-cell">Gamma Knife</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">50</td>
        <td class="naaccr-codes-cell">Brachytherapy, NOS</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">51</td>
        <td class="naaccr-codes-cell">Brachytherapy, Intracavitary, Low Dose Rate (LDR)</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">52</td>
        <td class="naaccr-codes-cell">Brachytherapy, Intracavitary, High Dose Rate (HDR)</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">53</td>
        <td class="naaccr-codes-cell">Brachytherapy, Interstitial, Low Dose Rate (LDR)</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">54</td>
        <td class="naaccr-codes-cell">Brachytherapy, Interstitial, High Dose Rate (HDR)</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">55</td>
        <td class="naaccr-codes-cell">Radium</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">60</td>
        <td class="naaccr-codes-cell">Radio-isotopes, NOS</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">61</td>
        <td class="naaccr-codes-cell">Strontium - 89</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">62</td>
        <td class="naaccr-codes-cell">Strontium - 90</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">80*</td>
        <td class="naaccr-codes-cell">Combination modality, specified</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">85*</td>
        <td class="naaccr-codes-cell">Combination modality, NOS</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">98</td>
        <td class="naaccr-codes-cell">Other, NOS</td>
    </tr>
    <tr>
        <td class="naaccr-codes-cell naaccr-codes-padding naaccr-codes-nowrap">99</td>
        <td class="naaccr-codes-cell">Unknown</td>
    </tr>
</table>
<br/>
  <p>
    <em>Note: </em>For tumors diagnosed prior to January 1, 2003, the codes  reported in this data item describe any radiation administered to the  patient as part or all of the first course of therapy. <br/><br/>  *Codes 80 and 85 describe specific converted descriptions of radiation  therapy coded according to <em>Volume II ROADS</em>, and<em> DAM </em>rules and should only be used to record regional radiation for tumors diagnosed prior to January 1, 2003. </p>

<br/>
